Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Compound 15a was effective in inhibiting 5α-reductase.

Type 2 5α-reductase plays a key role in hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

Finasteride safely lowers DHT levels without affecting testosterone.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Older patients sticking to their prostate medication saw lasting health benefits.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

SARMs work differently in tissues due to unique interactions and structures.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

We need better ways to test and understand SARMs to make safer and more effective treatments.